Manufacturers Should Perform Due Diligence On Potential Distributors, Attorney Advises
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug companies should audit wholesalers' facilities to reduce counterfeits, Arnall Golden Gregory attorney Alan Minsk tells Healthcare Distribution Management Association.
You may also be interested in...
Minn. Appellate Court Will Reconsider Access To GlaxoSmithKline Documents On Re-Importation
GlaxoSmithKline may be ordered to make public 45 documents related to Minnesota Attorney General's claim that the company attempted to boycott Canadian pharmacies.
Minn. Appellate Court Will Reconsider Access To GlaxoSmithKline Documents On Re-Importation
GlaxoSmithKline may be ordered to make public 45 documents related to Minnesota Attorney General's claim that the company attempted to boycott Canadian pharmacies.
Rx Imports From Canada Reimbursed By Minnesota Health Plan
HealthPartners is reimbursing beneficiaries for Canadian purchases, but not at the point of sale. Minnesota has asked HealthPartners to add Canadian pharmacies to its retail network and to accept electronic claims for drugs purchased abroad, but the health plan accepts only paper claims.